A small trial (Nix-TB) undertaken at three sites in South Africa to test the safety and efficacy of three oral drugs — bedaquiline, pretomanid and linezolid — in 109 patients (57 males and 56 females were HIV positive) with extensively drug-resistant TB (XDR-TB) and multidrug-resistant TB (MDR-TB) showed encouraging results — treatment success rate was 90%. The favourable results held true regardless of the HIV status of the patients.
If you want to change selection, open document below and click on "Move attachment"
Unknown titlents is at par with the success rate seen while treating drug-sensitive TB. | Photo Credit: pittawut The small trial using three oral drugs in 109 patients showed a treatment success rate of 90% <span>A small trial (Nix-TB) undertaken at three sites in South Africa to test the safety and efficacy of three oral drugs — bedaquiline, pretomanid and linezolid — in 109 patients (57 males and 56 females were HIV positive) with extensively drug-resistant TB (XDR-TB) and multidrug-resistant TB (MDR-TB) showed encouraging results — treatment success rate was 90%. The favourable results held true regardless of the HIV status of the patients. The treatment using the three oral drugs lasted for 26 weeks and was followed-up for six months after the end of the treatment. Patients received the treatment daily for 26 weeks. The t Summary
| status | not read | | reprioritisations | |
|---|
| last reprioritisation on | | | suggested re-reading day | |
|---|
| started reading on | | | finished reading on | |
|---|
Details